Intelligence methods for life sciences partnerships
Work through the decisions behind a commercial partnership.
A promising proposal still leaves work to do. Which problem should the partnership solve? Who can authorize the test? What would the results need to show?
Deal Design Intelligence publishes practical reports that help sponsors and providers work through those questions.
Free case analyses and new-report announcements by email.

Why this publication exists
Put the methods into practice.
Knowing the name of an analytic technique is only a start. The work is learning when to use it, what evidence to seek and how its findings should change a decision.
We created these reports to help professionals practise that work. Cases follow the questions behind an initial request, compare explanations and identify what still needs to be learned. Repeated application gives professionals a way to develop their judgment in the situations they face.
Begin with your decision
What needs to be clearer before the next commitment?
For pharma and biotech leaders
Agree on what the pilot must prove.
Work through the evidence finance, procurement and implementation each need.
For pharma leaders ↗For AI providers and CRO partners
Shape the offer around the evidence.
Test the buyer’s first request before fixing the scope of a proposal.
For providers and partners ↗For VC and portfolio teams
Examine what progress depends on.
Separate sponsor interest from the commitments that authorize a test.
For portfolio teams ↗An illustrative case
The first request may point to the wrong test.
A pharma team asks for faster competitive briefs. The vendor starts with a drafting offer. Work records show more effort going into finding and checking documents than writing. The vendor proposes a focused test of search instead.
Follow the reasoning, including what those records leave unresolved. The case adapts structured analytic techniques described by the U.S. Government (2009).
Follow the competitive briefs case
From the current issue
Deal Formation
From Interest to a Pilot Decision
Written for sponsors and AI providers, Report 01 follows a commercial partnership from initial interest through the pilot decision. Its examples focus on U.S. pharmaceutical commercial operations.
48-page PDF. Eight structured analytic techniques. $99 for one named reader.
The continuing series
Put better questions to work.
Subscribe to Deal Design Intelligence for practical cases, analysis and new-report announcements. Start with practical cases on the decisions behind enterprise AI partnerships in life sciences.
New analysis as it is published. Full reports are sold separately.
Strategic areas are optional. Leave them blank for the current enterprise AI partnership series, or select only the areas you want. Broader areas are proposed future coverage.
The sign-up form is loading.
Read how we handle information.